← Browse by Condition
Medical Condition
hidradenitis suppurativa
Total Trials
6
Recruiting Now
6
Trial Phases
Phase 1, Phase 2, Phase 2, EARLY_Phase 1
NCT06895499 Phase 1, Phase 2
Recruiting
Efficacy, Safety, and Tolerability of HB0043 in Hidradenitis Suppurativa Patients.
Enrollment
15 pts
Location
China
Sponsor
Shanghai Huaota Biopharmaceuti...
NCT07077902 Phase 2
Recruiting
A Study for Evaluating Safety & Efficacy of Topical Roflumilast 0.3% Foam in Hidradenitis Suppurativa
Enrollment
10 pts
Location
United States
Sponsor
Tulane University
NCT06368388
Recruiting
Bacteriophage Therapy for Difficult-to-treat Infections: the Implementation of a Multidisciplinary Phage Task Force
Enrollment
50 pts
Location
Belgium
Sponsor
Universitaire Ziekenhuizen KU ...
NCT05243966
Recruiting
Myriad™ Augmented Soft Tissue Reconstruction Registry
Enrollment
800 pts
Location
United States
Sponsor
Aroa Biosurgery Limited
NCT06524635 Phase 2
Recruiting
A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab
Enrollment
60 pts
Location
United States
Sponsor
AbbVie
NCT06058520 EARLY_Phase 1
Recruiting
Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa
Enrollment
16 pts
Location
United States
Sponsor
University of Minnesota